Home / CLBT : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does CLBT make money? Does CLBT have pricing power? What's the Earnings Whisper? Will CLBT profit more as the business scales? What is CLBT's management track record? Is CLBT's current price justified?

Cellebrite DI Ltd.

$11.23 -$6.61 (-37.05%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$11.32

Day Range

$11.05$11.5

Year Range

$9.58$19.98

Market Cap

2.8B

AVG Volume

2.69M

Trailing/Forward PE

47.71/29.95

PEG ratio

1.33

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

NASDAQ

Revenue (USD) · TTM

CLBT Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	514.29M
26 Q1	496.43M
25 Q4	475.68M
25 Q3	455.9M
25 Q2	436.73M
25 Q1	419.17M
24 Q4	401.2M
24 Q3	385.17M
24 Q2	362.49M
24 Q1	343.46M

Net Income (USD) · TTM

CLBT Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	58.76M
26 Q1	71.86M
25 Q4	78.33M
25 Q3	76.33M
25 Q2	-150.95M
25 Q1	-194.24M
24 Q4	-283.01M
24 Q3	-316.92M
24 Q2	-103.33M
24 Q1	-111.87M

Operating Income (USD) · TTM

CLBT Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	56.54M
26 Q1	63.33M
25 Q4	66.48M
25 Q3	61.4M
25 Q2	61.86M
25 Q1	59.93M
24 Q4	56.91M
24 Q3	56.18M
24 Q2	50.21M
24 Q1	42.35M

EBITDA (USD) · TTM

CLBT EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	113.64M
26 Q1	127.62M
25 Q4	128.94M
25 Q3	-234.93M
25 Q2	-239.86M
25 Q1	-255.32M
24 Q4	-265.35M
24 Q3	-41.99M
24 Q2	-48.2M
24 Q1	-56.07M

Cash Flows (USD) · TTM

CLBT Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	139.59M
26 Q1	154.04M
25 Q4	155.73M
25 Q3	139.11M
25 Q2	148.99M
25 Q1	132.18M
24 Q4	121.56M
24 Q3	98.79M
24 Q2	87.06M
24 Q1	90.65M

EPS (USD) · TTM

CLBT EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	0.23
26 Q1	0.29
25 Q4	0.31
25 Q3	0.31
25 Q2	-0.76
25 Q1	-0.96
24 Q4	-1.39
24 Q3	-1.55
24 Q2	-0.52
24 Q1	-0.57

Expenses (USD) · TTM

CLBT Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	383.5M
26 Q1	366.92M
25 Q4	347.25M
25 Q3	334.98M
25 Q2	318.72M
25 Q1	303.25M
24 Q4	292.31M
24 Q3	280.34M
24 Q2	265.46M
24 Q1	256M

Shares Outstanding (USD) · TTM

CLBT Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-29.69M
26 Q1	-38.5M
25 Q4	-32.9M
25 Q3	-42.16M
25 Q2	-35.9M
25 Q1	-33.65M
24 Q4	-30.56M
24 Q3	-26.36M
24 Q2	-22.19M
24 Q1	-20.24M

Employee Count

CLBT Employee Count by quarter
Period	Employee Count
2025	1.28K
2024	1.17K
2023	1.01K
2022	1K
2021	900

PE Ratio

CLBT PE Ratio by quarter
Period	PE Ratio
Sep 26	47.32
Sep 26	48.25
Aug 26	50.53
Aug 26	46.57
Aug 26	46.95
Aug 26	54.91
Jul 26	50.59
Jul 26	48.77
Jul 26	52.95
Jul 26	54.67
Jul 26	53.67
Jun 26	47.19
Jun 26	44
Jun 26	44.04
Jun 26	47.36
May 26	47.3
May 26	42.32
May 26	41.68
May 26	43.73
May 26	42.87
Apr 26	40.78
Apr 26	42.32
Apr 26	35.42
Apr 26	44.95
Mar 26	41.58
Mar 26	45.82
Mar 26	46.37
Mar 26	49.13
Feb 26	42.83
Feb 26	42.26
Feb 26	47.01
Feb 26	46.36
Jan 26	48.12
Jan 26	51.92
Jan 26	55.61
Jan 26	60.39
Jan 26	58.36
Dec 25	60.23
Dec 25	62.84
Dec 25	61.57
Dec 25	59.8
Nov 25	55.16
Nov 25	55.22
Nov 25	60.36
Aug 23	55.61
Jul 23	57.27
Jul 23	57.27
Jul 23	52.53
Jul 23	51.62
Jun 23	54.18
Jun 23	47.71
Jun 23	48.39
Jun 23	46.28
Jun 23	42.97
May 23	43.65
May 23	41.99
May 23	41.16
May 23	8.27
Apr 23	8.28
Apr 23	8.85
Apr 23	8.79
Apr 23	8.57
Mar 23	9.32
Mar 23	8.97
Mar 23	8.85
Mar 23	8.99
Mar 23	9.37
Feb 23	8.83
Feb 23	8.8
Feb 23	5.93
Feb 23	6.46
Jan 23	6.17
Jan 23	5.35
Jan 23	5.12
Jan 23	5.19
Dec 22	5.08
Dec 22	4.87
Dec 22	5.06
Dec 22	5
Dec 22	5.21
Nov 22	5.4
Nov 22	5.38
Nov 22	6.33
Nov 22	6.23
Oct 22	6.3
Oct 22	6.19
Oct 22	5.55
Oct 22	5.61
Sep 22	5.09
Sep 22	5.59
Sep 22	5.68
Sep 22	5.94
Sep 22	6.19
Aug 22	6.24
Aug 22	6.36
Aug 22	6.94
Aug 22	9.07
Jul 22	8.04
Jul 22	8.8
Jul 22	8.34

Free Cash Flow Yield

CLBT Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	5.02%
Sep 26	4.92%
Aug 26	4.7%
Aug 26	5.1%
Aug 26	5.06%
Aug 26	3.9%
Jul 26	4.24%
Jul 26	4.4%
Jul 26	4.05%
Jul 26	3.92%
Jul 26	3.99%
Jun 26	4.54%
Jun 26	4.87%
Jun 26	4.87%
Jun 26	4.53%
May 26	4.2%
May 26	4.7%
May 26	4.77%
May 26	4.55%
May 26	4.64%
Apr 26	4.88%
Apr 26	4.7%
Apr 26	5.61%
Apr 26	4.42%
Mar 26	4.78%
Mar 26	4.34%
Mar 26	4.29%
Mar 26	4.05%
Feb 26	4.64%
Feb 26	4.71%
Feb 26	4.23%
Feb 26	3.93%
Jan 26	3.79%
Jan 26	3.51%
Jan 26	3.28%
Jan 26	3.02%
Jan 26	3.12%
Dec 25	3.03%
Dec 25	2.9%
Dec 25	2.96%
Dec 25	3.05%
Nov 25	3.3%
Nov 25	3.3%
Nov 25	3.02%
Nov 25	4.03%
Oct 25	3.63%
Oct 25	3.32%
Oct 25	3.41%
Oct 25	3.25%
Oct 25	3.33%
Sep 25	3.33%
Sep 25	3.52%
Sep 25	3.69%
Sep 25	3.73%
Aug 25	3.78%
Aug 25	3.85%
Aug 25	3.97%
Aug 25	3.92%
Aug 25	3.88%
Jul 25	3.71%
Jul 25	3.7%
Jul 25	3.64%
Jul 25	3.44%
Jun 25	3.36%
Jun 25	3.44%
Jun 25	3.37%
Jun 25	3.22%
May 25	3.19%
May 25	3.09%
May 25	3.05%
May 25	2.63%
May 25	2.59%
Apr 25	2.65%
Apr 25	2.76%
Apr 25	2.71%
Apr 25	2.94%
Mar 25	2.68%
Mar 25	2.71%
Mar 25	2.59%
Mar 25	2.69%
Feb 25	2.55%
Feb 25	2.48%
Feb 25	2.31%
Feb 25	1.86%
Jan 25	1.97%
Jan 25	2%
Jan 25	2.08%
Jan 25	2.19%
Jan 25	2.14%
Dec 24	2.13%
Dec 24	2.1%
Dec 24	2.38%
Dec 24	2.22%
Nov 24	2.35%
Nov 24	2.4%
Nov 24	2.67%
Nov 24	2.54%
Nov 24	2.36%
Oct 24	2.39%
Oct 24	2.41%

Price to Sales

CLBT Price to Sales by quarter
Period	Price to Sales
Sep 26	5.41
Sep 26	5.51
Aug 26	5.77
Aug 26	5.32
Aug 26	5.36
Aug 26	7.95
Jul 26	7.32
Jul 26	7.06
Jul 26	7.67
Jul 26	7.91
Jul 26	7.77
Jun 26	6.83
Jun 26	6.37
Jun 26	6.37
Jun 26	6.86
May 26	7.79
May 26	6.97
May 26	6.86
May 26	7.2
May 26	7.06
Apr 26	6.71
Apr 26	6.97
Apr 26	5.83
Apr 26	7.4
Mar 26	6.85
Mar 26	7.54
Mar 26	7.63
Mar 26	8.09
Feb 26	7.05
Feb 26	6.96
Feb 26	7.74
Feb 26	7.76
Jan 26	8.06
Jan 26	8.69
Jan 26	9.31
Jan 26	10.11
Jan 26	9.77
Dec 25	10.08
Dec 25	10.52
Dec 25	10.31
Dec 25	10.01
Nov 25	9.24
Nov 25	9.25
Nov 25	10.11
Nov 25	8.48
Oct 25	9.39
Oct 25	10.27
Oct 25	10.01
Oct 25	10.51
Oct 25	10.25
Sep 25	10.25
Sep 25	9.69
Sep 25	9.25
Sep 25	9.14
Aug 25	9.03
Aug 25	8.87
Aug 25	8.59
Aug 25	8.05
Aug 25	8.12
Jul 25	8.49
Jul 25	8.53
Jul 25	8.65
Jul 25	9.16
Jun 25	9.39
Jun 25	9.17
Jun 25	9.36
Jun 25	9.8
May 25	9.89
May 25	10.21
May 25	10.32
May 25	11.53
May 25	11.71
Apr 25	11.42
Apr 25	10.99
Apr 25	11.17
Apr 25	10.3
Mar 25	11.31
Mar 25	11.18
Mar 25	9.89
Mar 25	9.52
Feb 25	10.06
Feb 25	10.36
Feb 25	11.11
Feb 25	13.77
Jan 25	13.03
Jan 25	12.84
Jan 25	12.34
Jan 25	11.69
Jan 25	11.98
Dec 24	12.03
Dec 24	12.2
Dec 24	10.77
Dec 24	11.57
Nov 24	10.93
Nov 24	10.69
Nov 24	9.59
Nov 24	10.08
Nov 24	10.17
Oct 24	10.04
Oct 24	9.96

EV/EBITDA

CLBT EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	20.78
Sep 26	21.26
Aug 26	22.44
Aug 26	20.39
Aug 26	20.58
Aug 26	27.74
Jul 26	25.3
Jul 26	24.28
Jul 26	26.64
Jul 26	27.6
Jul 26	27.04
Jun 26	23.39
Jun 26	21.59
Jun 26	21.61
Jun 26	23.49
May 26	25.52
May 26	22.49
May 26	22.1
May 26	23.35
May 26	22.83
Apr 26	21.56
Apr 26	22.49
Apr 26	18.3
Apr 26	24.09
Mar 26	22.05
Mar 26	24.62
Mar 26	24.95
Mar 26	26.63
Feb 26	22.81
Feb 26	22.46
Feb 26	25.34
Mar 24	12.43
Mar 24	12.31
Mar 24	13.33
Feb 24	12.63
Feb 24	12.24
Feb 24	9.86
Feb 24	9.59
Jan 24	9.64
Jan 24	8.77
Jan 24	8.35
Jan 24	8.4
Dec 23	8.92
Dec 23	9.05
Dec 23	8.41
Dec 23	8.79
Dec 23	8.63
Nov 23	8.13
Nov 23	7.61
Nov 23	6.89
Nov 23	6.8
Oct 23	5.87
Oct 23	6.43
Oct 23	6.51
Oct 23	7.14
Sep 23	7.21
Sep 23	6.98
Sep 23	6.92
Sep 23	7.47
Sep 23	7.81
Aug 23	7.26
Aug 23	7.16
Aug 23	7.27
Aug 23	6.05
Jul 23	6.26
Jul 23	6.26
Jul 23	5.67
Jul 23	5.55
Jun 23	5.87
Jun 23	5.06
Jun 23	5.14
Jun 23	4.88
Jun 23	4.46
May 23	4.55
May 23	4.34
May 23	4.23
May 23	3.32
Apr 23	3.32
Apr 23	3.6
Apr 23	3.57
Apr 23	3.46
Mar 23	3.83
Mar 23	3.66
Mar 23	3.6
Mar 23	3.66
Mar 23	3.85
Feb 23	3.59
Feb 23	3.58
Feb 23	4.33
Feb 23	4.78
Jan 23	4.53
Jan 23	3.83
Jan 23	3.63
Jan 23	3.69
Dec 22	3.6
Dec 22	3.42
Dec 22	3.58
Dec 22	3.53
Dec 22	3.71
Nov 22	3.88

Price/Operating Cashflow

CLBT Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	18.18
Sep 26	18.53
Aug 26	19.41
Aug 26	17.89
Aug 26	18.03
Aug 26	23.49
Jul 26	21.64
Jul 26	20.87
Jul 26	22.66
Jul 26	23.39
Jul 26	22.96
Jun 26	20.19
Jun 26	18.83
Jun 26	18.84
Jun 26	20.26
May 26	21.93
May 26	19.62
May 26	19.32
May 26	20.27
May 26	19.87
Apr 26	18.9
Apr 26	19.62
Apr 26	16.42
Apr 26	20.84
Mar 26	19.28
Mar 26	21.24
Mar 26	21.49
Mar 26	22.77
Feb 26	19.86
Feb 26	19.59
Feb 26	21.79
Feb 26	23.17
Jan 26	24.06
Jan 26	25.95
Jan 26	27.8
Jan 26	30.19
Jan 26	29.17
Dec 25	30.11
Dec 25	31.42
Dec 25	30.78
Dec 25	29.89
Nov 25	27.57
Nov 25	27.6
Nov 25	30.17
Nov 25	22.98
Oct 25	25.46
Oct 25	27.84
Oct 25	27.13
Oct 25	28.5
Oct 25	27.78
Sep 25	27.8
Sep 25	26.28
Sep 25	25.07
Sep 25	24.79
Aug 25	24.47
Aug 25	24.04
Aug 25	23.28
Aug 25	23.59
Aug 25	23.81
Jul 25	24.89
Jul 25	25
Jul 25	25.36
Jul 25	26.86
Jun 25	27.52
Jun 25	26.89
Jun 25	27.43
Jun 25	28.73
May 25	28.99
May 25	29.91
May 25	30.26
May 25	35.01
May 25	35.54
Apr 25	34.66
Apr 25	33.35
Apr 25	33.92
Apr 25	31.25
Mar 25	34.34
Mar 25	33.94
Mar 25	34.62
Mar 25	33.33
Feb 25	35.2
Feb 25	36.27
Feb 25	38.88
Feb 25	48.2
Jan 25	45.6
Jan 25	44.95
Jan 25	43.21
Jan 25	40.91
Jan 25	41.92
Dec 24	42.11
Dec 24	42.72
Dec 24	37.71
Dec 24	40.5
Nov 24	38.28
Nov 24	37.4
Nov 24	33.57
Nov 24	35.3
Nov 24	37.79
Oct 24	37.3
Oct 24	37.01

Price to Book

CLBT Price to Book by quarter
Period	Price to Book
Sep 26	5.17
Sep 26	5.27
Aug 26	5.52
Aug 26	5.08
Aug 26	5.13
Aug 26	7.73
Jul 26	7.12
Jul 26	6.86
Jul 26	7.45
Jul 26	7.7
Jul 26	7.56
Jun 26	6.64
Jun 26	6.19
Jun 26	6.2
Jun 26	6.67
May 26	7.65
May 26	6.84
May 26	6.74
May 26	7.07
May 26	6.93
Apr 26	6.59
Apr 26	6.84
Apr 26	5.73
Apr 26	7.27
Mar 26	6.72
Mar 26	7.41
Mar 26	7.5
Mar 26	7.95
Feb 26	6.93
Feb 26	6.83
Feb 26	7.6
Feb 26	7.9
Jan 26	8.21
Jan 26	8.85
Jan 26	9.48
Jan 26	10.3
Jan 26	9.95
Dec 25	10.27
Dec 25	10.72
Dec 25	10.5
Dec 25	10.2
Nov 25	9.4
Nov 25	9.42
Nov 25	10.29
Nov 25	9.06
Oct 25	10.04
Oct 25	10.98
Oct 25	10.7
Oct 25	11.24
Oct 25	10.96
Sep 25	10.96
Sep 25	10.36
Sep 25	9.89
Sep 25	9.78
Aug 25	9.65
Aug 25	9.48
Aug 25	9.18
Aug 25	9.28
Aug 25	9.37
Jul 25	9.79
Jul 25	9.83
Jul 25	9.98
Jul 25	10.57
Jun 25	10.83
Jun 25	10.58
Jun 25	10.79
Jun 25	11.3
May 25	11.41
May 25	11.77
May 25	11.91
May 25	13.77
May 25	13.98
Apr 25	13.63
Apr 25	13.12
Apr 25	13.34
Apr 25	12.29
Mar 25	13.51
Mar 25	13.35
Mar 25	12.77
Mar 25	12.29
Feb 25	12.98
Feb 25	13.38
Feb 25	14.34
Feb 25	17.78
Jan 25	16.82
Jan 25	16.58
Jan 25	15.94
Jan 25	15.09
Jan 25	15.46
Dec 24	15.53
Dec 24	15.76
Dec 24	13.91
Dec 24	14.94
Nov 24	14.12
Nov 24	13.8
Nov 24	12.38
Nov 24	13.02
May 24	65.53
May 24	62.8
May 24	60.93

No video analysis for this stock yet. Request one from our team.

News: CLBT

newsfilecorp.com · 10 Sep 2026

Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation

New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).

newsfilecorp.com · 8 Sep 2026

Kaplan Fox Urges Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm About Possible Securities Law Violations

New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).

defenseworld.net · 8 Sep 2026

Cellebrite DI (NASDAQ:CLBT) and Riskified (NYSE:RSKD) Head to Head Contrast

Riskified (NYSE: RSKD - Get Free Report) and Cellebrite DI (NASDAQ: CLBT - Get Free Report) are both technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Earnings and Valuation This table compares Riskified and Cellebrite

newsfilecorp.com · 4 Sep 2026

Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).

prnewswire.com · 4 Sep 2026

Cellebrite Announces Upcoming Investor Events in September

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.

prnewswire.com · 4 Sep 2026

Cellebrite anuncia próximos eventos para inversores en septiembre

/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público

prnewswire.com · 4 Sep 2026

Cellebrite annonce des événements destinés aux investisseurs en septembre

/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), leader mondial des solutions d'enquête et de renseignement numériques alimentées par l'IA pour les secteurs

prnewswire.com · 4 Sep 2026

Cellebrite kündigt für September bevorstehende Investorenveranstaltungen an

/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und

AI Analysis

Cellebrite DI Ltd.

Video analysis: CLBT

News: CLBT

Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation

Kaplan Fox Urges Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm About Possible Securities Law Violations

Cellebrite DI (NASDAQ:CLBT) and Riskified (NYSE:RSKD) Head to Head Contrast

Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights

Cellebrite Announces Upcoming Investor Events in September

Cellebrite anuncia próximos eventos para inversores en septiembre

Cellebrite annonce des événements destinés aux investisseurs en septembre

Cellebrite kündigt für September bevorstehende Investorenveranstaltungen an

Similar companies